MedPath

The effects of nicotinic acid on hyperphosphatemia in dialysis patients of valiasr-Arak center

Not Applicable
Conditions
Hyperphosphatemia.
disorder of phosphorus metabolism
Registration Number
IRCT138812153492N1
Lead Sponsor
Depuity of education & research of Arak university of Medical science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Inclusion criteria : Age > 18&<90 years, sign satisfaction, serum phosphorous: 5-7 mg/day , unchanged treatment protocol , (calcium components and Vit D) during last two weeks , unchanged dialysis protocol. Exclusion criteria: pregnancy, known liver disease, active peptic ulcer, carbamazepine use, drug intolerance.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath